The market for Companion Diagnostics Development Services is valued at over USD 800 million; Roots Analysis projects growth at an annualized rate of ~5% through 2030. A record number of personalized therapeutic products have been approved in the US in recent years, creating an urgent need for companion diagnostics and prompting many drug developers to actively seek external support and...